The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells
- PMID: 16458258
- DOI: 10.1016/j.bcp.2005.12.033
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells
Abstract
Cannabis is the most widely used illicit drug in the world. Cannabinoids are used therapeutically by some patients as they have analgesic, anti-emetic and appetite stimulant properties which palliate adverse symptoms. Use of these agents in an oncology setting raises the question of whether they act to modulate the effectiveness of concurrently administered anti-cancer drugs. The transporter, P-glycoprotein (P-gp) confers multiple drug resistance (MDR) by effluxing a diverse array of anti-cancer agents. This study was undertaken to examine the effect of cannabinoids on P-gp. Unlike the known P-gp inhibitor, PSC833, short 1h exposure to three plant-derived cannabinoids, cannabinol (CBN), cannabidiol (CBD) and Delta(9)-tetrahydrocannabinol (THC) and the synthetic cannabinoid receptor agonist, WIN55, 212-2 (WIN) did not inhibit the efflux of the P-gp substrate Rhodamine 123 (Rh123) in either a drug-selected human T lymphoblastoid leukaemia cell line (CEM/VLB(100)) or in a mouse fibroblast MDR1 transfected cell line (77.1). However, in CEM/VLB(100) cells, prolonged 72 h exposure to the cannabinoids, THC and CBD, decreased P-gp expression to a similar extent as the flavonoid, curcumin (turmeric). This correlated with an increase in intracellular accumulation of Rh123 and enhanced sensitivity of the cells to the cytotoxic actions of the P-gp substrate, vinblastine. Taken together, these results provide preliminary evidence that cannabinoids do not exacerbate P-gp mediated MDR. Further, plant-derived cannabinoids are moderately effective in reversing MDR in CEM/VLB(100) cells by decreasing P-gp expression.
Similar articles
-
Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.Cancer Chemother Pharmacol. 2002 May;49(5):391-7. doi: 10.1007/s00280-001-0411-5. Epub 2002 Feb 14. Cancer Chemother Pharmacol. 2002. PMID: 11976833
-
Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.J Pharmacol Exp Ther. 2006 May;317(2):850-7. doi: 10.1124/jpet.105.098541. Epub 2006 Jan 26. J Pharmacol Exp Ther. 2006. PMID: 16439618
-
Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.Acta Pharmacol Sin. 2005 Aug;26(8):1009-16. doi: 10.1111/j.1745-7254.2005.00149.x. Acta Pharmacol Sin. 2005. PMID: 16038636
-
Multidrug resistance of acute leukemia and a strategy to overcome it.Int J Hematol. 2000 Dec;72(4):418-24. Int J Hematol. 2000. PMID: 11197207 Review.
-
Does any relationship exist between P-glycoprotein-mediated multidrug resistance and intracellular calcium homeostasis.Gen Physiol Biophys. 2009;28 Spec No Focus:F89-95. Gen Physiol Biophys. 2009. PMID: 20093732 Review.
Cited by
-
Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines.PeerJ. 2013 Sep 12;1:e153. doi: 10.7717/peerj.153. eCollection 2013. PeerJ. 2013. PMID: 24058883 Free PMC article.
-
Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment.Cancers (Basel). 2023 Apr 1;15(7):2119. doi: 10.3390/cancers15072119. Cancers (Basel). 2023. PMID: 37046779 Free PMC article. Review.
-
In Vitro Screening of Three Commercial Cannabis-Based Products on ATP-Binding Cassette and Solute-Carrier Transporter Function.Cannabis Cannabinoid Res. 2022 Jun;7(3):304-317. doi: 10.1089/can.2020.0053. Epub 2020 Sep 22. Cannabis Cannabinoid Res. 2022. PMID: 33998860 Free PMC article.
-
Antimicrobial and Cytotoxic Effects of Cannabinoids: An Updated Review with Future Perspectives and Current Challenges.Pharmaceuticals (Basel). 2022 Oct 6;15(10):1228. doi: 10.3390/ph15101228. Pharmaceuticals (Basel). 2022. PMID: 36297340 Free PMC article. Review.
-
The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids.Br J Pharmacol. 2007 Nov;152(5):815-24. doi: 10.1038/sj.bjp.0707467. Epub 2007 Oct 1. Br J Pharmacol. 2007. PMID: 17906686 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous